Company Profile
Hyperfine Stock Price, News & Analysis
- Ticker:
- HYPR
- Exchange:
- NASDAQ
- Sector:
- Biopharma
- Location:
- United States
Stock performance
0.98 USD (+0.20%)
Close
Last updated: August 6, 2026
149M USD
Market cap
Why the stock is moving
The latest monitored company update is “Hyperfine, Inc. Reports Second Quarter 2026 Financial Results.” The corresponding closing-price reaction is not yet available.
Company overview
Portable Brain MRI Company
Hyperfine develops the Swoop portable magnetic resonance brain-imaging system for use at the patient’s bedside and in settings without conventional MRI infrastructure.
Low-Field Imaging Platform
Swoop uses low-field magnetic resonance and can be moved through hospitals, reducing the logistical burden of transporting critically ill patients.
AI Reconstruction
Optive AI software improves image acquisition and reconstruction, supporting neurological and stroke assessment on the portable platform.
International Commercialization
FDA clearance, CE Marking, and UKCA approval support commercialization in the United States, Europe, and the United Kingdom.
Future catalysts
For Hyperfine, the near-term story still runs through FDA-cleared and AI-powered. Recent commentary puts the focus on continued work around FDA-cleared and AI-powered and the next company-specific development update. That leaves the stock tied to whether the next milestone lands on schedule.
Recent news
- 01
Hyperfine, Inc. Reports Second Quarter 2026 Financial Results
Source: Hyperfine
- 02
- 03
- 04
Hyperfine Announces European Launch of Next-Generation Swoop® System
Source: Hyperfine
- 05
Similar stocks
Peer names with similar commercial maturity, therapeutic overlap, or catalyst patterns.
Frequently Asked Questions
What is the current stock price of Hyperfine (HYPR)?
Hyperfine (HYPR) most recently closed at 0.98 USD, a +0.20% move versus the previous session.
What is the market cap of Hyperfine (HYPR)?
Hyperfine currently has a market capitalization of 149M USD on BioPharmSignal.
What does Hyperfine do?
Portable Brain MRI Company Hyperfine develops the Swoop portable magnetic resonance brain-imaging system for use at the patient’s bedside and in settings without conventional MRI infrastructure. Low-Field Imaging Platform Swoop uses low-field magnetic resonance and can be moved through hospitals, reducing the logistical burden of transporting critically ill...
On which exchange is HYPR stock listed?
Hyperfine (HYPR) is associated with NASDAQ, United States, Biopharma.
What is Portable?
Portable Brain MRI Company Hyperfine develops the Swoop portable magnetic resonance brain-imaging system for use at the patient’s bedside and in settings without conventional MRI infrastructure.
Which conditions is Hyperfine targeting with Portable?
Portable Brain MRI Company Hyperfine develops the Swoop portable magnetic resonance brain-imaging system for use at the patient’s bedside and in settings without conventional MRI infrastructure. Low-Field Imaging Platform Swoop uses low-field magnetic resonance and can be moved through hospitals, reducing the logistical burden of transporting critically ill...
How does Hyperfine describe recent progress with Portable?
For Hyperfine, the near-term story still runs through FDA-cleared and AI-powered. Recent commentary puts the focus on continued work around FDA-cleared and AI-powered and the next company-specific development update. That leaves the stock tied to whether the next milestone lands on schedule.
What is Brain?
Portable Brain MRI Company Hyperfine develops the Swoop portable magnetic resonance brain-imaging system for use at the patient’s bedside and in settings without conventional MRI infrastructure.